http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1809107-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b8499101ca5ffb51778f7b16e7f7a8a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-245
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N59-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-305
filingDate 2005-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eae8b5461b5b9e33dc6b406ba18b971e
publicationDate 2007-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1809107-A2
titleOfInvention Compositions and methods of dispensing palliative or therapeutic agents
abstract The present invention is a palliative or therapeutic foam for medicating or treating affected biological tissue having a pH of 7.0 to 8.0 and including a hydrated dialkali monometal complex such as disodium monocopper(II) citrate dihydrate,or disodium monozinc(II) citrate dihydrate and triethanolamine lauryl sulfate in a concentration of less than 10%.
priorityDate 2004-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006047556-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4652444-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0115130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006081358-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-968843-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0399858-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415369
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226533822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226473550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226473549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10431981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87066029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49873736
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226511216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128320325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127743768
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56943387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226511215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400247

Total number of triples: 60.